Abstract
Discovery of neural mechanisms underlying neuropsychiatric disorders within the aging and addiction fields has been a main focus of the National Institutes of Health. However, there is a dearth of knowledge regarding the biological interactions of aging and addiction, which may have important influences on progression of disease and treatment outcomes in aging individuals with a history of chronic drug use. Thus, there is a large gap in these fields of research, which has slowed progress in understanding and treating substance use disorders (SUDs) as well as age-related diseases, specifically in women who experience precipitous reproductive cycle transitions during aging. The goal of this review is to highlight overlap of SUDs and age-related processes with a specific focus on menopause and smoking, and identify critical gaps. We have narrowed the focus of the review to smoking, as the majority of findings on hormonal and aging influences on drug use have come from this area of research. Further, we highlight female-specific issues such as transitional menopause and exogenous estrogen use. These issues may impact drug use cessation as well as outcomes with aging and age-related neurodegenerative diseases in women. We first review clinical studies for smoking, normal aging, and pathological aging, and discuss the few aging-related studies taking smoking history into account. Conversely, we highlight the dearth of clinical smoking studies taking age as a biological variable into account. Preclinical and clinical literature show that aging, age-related pathological brain disease, and addiction engage overlapping neural mechanisms. We hypothesize that these putative drivers interact in meaningful ways that may exacerbate disease and hinder successful treatment outcomes in such comorbid populations. We highlight areas where preclinical studies are needed to uncover neural mechanisms in aging and addiction processes. Collectively, this review highlights the need for crosstalk between different fields of research to address medical complexities of older adults, and specifically women, who smoke.
| Original language | English |
|---|---|
| Pages (from-to) | 112-122 |
| Number of pages | 11 |
| Journal | Behavioural Pharmacology |
| Volume | 32 |
| Issue number | 23 |
| DOIs | |
| State | Published - Apr 1 2021 |
Bibliographical note
Publisher Copyright:©2020 Wolters Kluwer Health, Inc. All rights reserved.
Funding
This work was supported by the following grants from the National Institutes of Health: NIDA DA046526, DA036569, DA044479, and DA045881 (to CDG), and the Arizona Alzheimer’s Consortium (to CDG and HBN). Dr. Heather Bimonte-Nelson is funded by the following grant awards: NIA (AG028084), state of Arizona, Arizona Department of Health Services (ADHS14-052688), and NIH Alzheimer’s Disease Core Center (P30AG019610). Recently, there have been significant efforts to discover neurobiological mechanisms driving neuropsychiatric disorders within the aging and addiction fields. The goal of these efforts is the discovery of novel efficacious treatments. Alzheimer’s disease and opioid use disorder have received significant increases in funding from the National Institutes of Health. Since 2014, the National Institute on Aging in the United States has devoted $1.7 billion to Alzheimer’s Research, constituting a significant percentage of the funding portfolio of the institute (National Institute on Aging, 2018). Between 2016 and 2018, the National Institute on Drug Abuse received a doubled budget to combat the opioid epidemic (from $600 million to $1.1 billion; National Institutes of Health, 2018). Although these individual institutes have received increased funding to combat these disorders, there is a dearth of knowledge regarding how aging and addiction interact biologically, which may have an important
| Funders | Funder number |
|---|---|
| NIH Alzheimer’s Disease Core Center | |
| National Institutes of Health (NIH) | |
| Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug Abuse | DA044479, R00DA036569, DA046526, DA045881 |
| National Institute on Aging | ADHS14-052688, AG028084, P30AG019610 |
| Banner Alzheimer’s Institute and Arizona Alzheimer’s Consortium |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- addiction
- aging
- clinical
- hormone
- menopause
- neurobiology
- rodent
ASJC Scopus subject areas
- Pharmacology
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Interactions between reproductive transitions during aging and addiction: promoting translational crosstalk between different fields of research'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver